Teva Pharmaceutical Industries Ltd. - Did you know that 4.5 to 5.9 million Americans suffer from a severe form of #asthma called #eosinophilic asthma? Learn more about the condition in this infographic! #WorldAsthmaDay | Facebook
Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva Pharmaceuticals buys smart inhaler company Gecko Health Innovations | MobiHealthNews
Teva Pharmaceuticals on Twitter: "This month is National Asthma and Allergy Awareness Month and identifying and avoiding #asthma triggers is an important part of asthma management. Read and learn more here: https://t.co/CkL08njkXr #
Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire
Teva Wins FDA Approval for Digital Inhaler Combining Powder with Sensors, App
Teva to Present Findings on Short-Acting Beta Agonist (SABA) Use in Asthma Patients and the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Help Inform Treatment Decisions at American Thoracic Society
Teva Pharmaceutical touts real-world data on ProAir Digihaler for asthma (NYSE:TEVA) | Seeking Alpha
Buying Proair HFA Generic Salbutamol - Asthma Inhalers from Canada
Teva Inhalation Aerosol Approved by FDA for Children 4 and Over - Pharmaceutical Processing World
Salamol 100micrograms/dose Easi-Breathe inhaler (Teva UK Ltd) 200 dose - RightBreathe
Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development
Teva launches digital asthma and COPD rescue inhaler in US | pharmaphorum
Teva's severe eosinophilic asthma drug Cinqaero wins EU approval
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthma
Qvar 100 inhaler (Teva UK Ltd) 200 dose - RightBreathe
Teva Launches 2 New Digital Maintenance Inhalers
Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform
Teva's Novel Multidose Dry Powder Inhalers Reveal Positive Outcomes for Asthma Patients - Lung Disease News
Teva Pharmaceuticals Europe - Home | Facebook
Teva Canada commercialises Aermony RespiClick for bronchial asthma
